Xhale Assurance announced today that it will showcase its Nasal Alar SpO2 Sensor at the AANA2017 Nurse Anesthesia Annual Congress, hosted by the American Association of Nurse Anesthetists. The Congress will be taking place September 9 – 12, 2017 at the Washington State Convention Center, halls 4A and 4B in Seattle, WA. Xhale Assurance will […]
Xhale submits Biomarker Qualification package to FDA for Medication Adherence Monitoring Tool. Gainesville, FL, September 21, 2015 Xhale, Inc. announced today that it has submitted to the Food and Drug Administration (FDA) the first Biomarker Qualification package for a Drug Development Tool for medication adherence monitoring. The submittal to FDA marks an important step […]
Xhale Assurance announced today that it has received CE Mark approval for its Nasal Alar SpO2 Sensor which allows for nasal ala oximetry utilizing a highly dependable central site. GAINESVILLE, FL August 21, 2015 – Xhale Assurance, Inc. Xhale Assurance, Inc. today announced it has received CE Mark approval of its Nasal Alar […]
Xhale Assurance, Inc., developer of the patented Assurance® Nasal AlarSpO2TM Sensor, today announced FDA clearance and the global launch of its second-generation pulse oximetry sensor. The new Assurance® Nasal AlarSpO2TM Sensor is now compatible with the majority of pulse oximetry monitors in use in a wide variety of health care settings. “The Assurance® Nasal AlarSpO2TM […]
